The Future of Psychedelic Medicine

Our Story

Find out what inspires us to support mental health disorders.

Our Mission

Supporting innovative therapies to help humans thrive.

Our Team

Multi-Disciplinary Collaboration
creating positive experiences and outcomes.


Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.



HAVN Retail

Psychedelic medicine is the frontier of mental health and wellness

Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainability resourced compounds derived from fungi and plant medicines.


350 Million

People globally are affected by a form of depression.

1 Trillion

Dollars lost annually in global workforce productivity due to depression and anxiety.


Formulas standardized across clinical studies of psychedelic compounds.

HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.

Press Releases

Havn Life Sciences submits range of natural health products to Health Canada

Havn Retail, a core pillar of Havn Life continues to reach milestones as the company works towards its launch of a line of retail products …

Read More →
Press Releases

Havn Life Sciences announces listing approval on the Frankfurt Stock Exchange

Havn Life is now cross-listed and trades on both the CSE & FSE  Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE : 5NP)(the …

Read More →
Press Releases

Havn Life Sciences granted Section 56 exemption to begin scientific work with psilocybin

Havn Life will develop methods for safe, standardized, quality- controlled production of medical compounds extracted from the Psilocybe spp. mushroom September 10, 2020 Vancouver, BC …

Read More →
Scroll to Top